BAY 12-8039, a novel fluoroquinolone
- 1 September 1998
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 32 (1) , 45-50
- https://doi.org/10.1016/s0732-8893(98)00042-x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- In vitro activity of BAY 12-8039, a new fluoroquinolone, against species representative of respiratory tract pathogensInternational Journal of Antimicrobial Agents, 1998
- Antipneumococcal activity of BAY 12-8039, a new quinolone, compared with activities of three other quinolones and four oral beta-lactamsAntimicrobial Agents and Chemotherapy, 1997
- Comparison of the antibacterial activities of the quinolones Bay 12- 8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin [published erratum appears in J Antimicrob Chemother 1998 Jun;41(6):672]Journal of Antimicrobial Chemotherapy, 1997
- News from the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)Inpharma Weekly, 1997
- In vitro activity of Bay 12-8039, a new 8-methoxyquinoloneAntimicrobial Agents and Chemotherapy, 1997
- In vitro activity of Bay 12-8039, a new 8-methoxyquinolone, compared to the activities of 11 other oral antimicrobial agents against 390 aerobic and anaerobic bacteria isolated from human and animal bite wound skin and soft tissue infections in humansAntimicrobial Agents and Chemotherapy, 1997
- In vitro activity of BAY 12-8039, a novel 8-methoxyquinolone, compared to activities of six fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalisAntimicrobial Agents and Chemotherapy, 1997
- Pharmacodynamic properties of BAY 12-8039 on gram-positive and gram-negative organisms as demonstrated by studies of time-kill kinetics and postantibiotic effectAntimicrobial Agents and Chemotherapy, 1997
- In vitro activity of BAY 12-8039, a new fluoroquinoloneAntimicrobial Agents and Chemotherapy, 1997